Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection
View ORCID ProfileAfrah Khairallah, Zesuliwe Jule, Alice Piller, View ORCID ProfileMallory Bernstein, Kajal Reedoy, Yashica Ganga, Bernadett I. Gosnell, Farina Karim, View ORCID ProfileYunus Moosa, View ORCID ProfileThumbi Ndung’u, Khadija Khan, View ORCID ProfileAlex Sigal
doi: https://doi.org/10.1101/2024.08.21.24312063
Afrah Khairallah
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Zesuliwe Jule
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Alice Piller
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Mallory Bernstein
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Kajal Reedoy
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Yashica Ganga
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Bernadett I. Gosnell
2Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Farina Karim
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Yunus Moosa
2Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Thumbi Ndung’u
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
3HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa
4Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA
5Division of Infection and Immunity, University College London, London, UK
Khadija Khan
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
Alex Sigal
1Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa
6The Lautenberg Center for Immunology and Cancer Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
Article usage
Posted August 21, 2024.
Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection
Afrah Khairallah, Zesuliwe Jule, Alice Piller, Mallory Bernstein, Kajal Reedoy, Yashica Ganga, Bernadett I. Gosnell, Farina Karim, Yunus Moosa, Thumbi Ndung’u, Khadija Khan, Alex Sigal
medRxiv 2024.08.21.24312063; doi: https://doi.org/10.1101/2024.08.21.24312063
Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection
Afrah Khairallah, Zesuliwe Jule, Alice Piller, Mallory Bernstein, Kajal Reedoy, Yashica Ganga, Bernadett I. Gosnell, Farina Karim, Yunus Moosa, Thumbi Ndung’u, Khadija Khan, Alex Sigal
medRxiv 2024.08.21.24312063; doi: https://doi.org/10.1101/2024.08.21.24312063
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2881)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12617)
- Forensic Medicine (10)
- Gastroenterology (812)
- Genetic and Genomic Medicine (4483)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (910)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4245)
- Nursing (228)
- Nutrition (622)
- Oncology (2225)
- Ophthalmology (633)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (490)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6829)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (376)
- Surgery (475)
- Toxicology (60)
- Transplantation (206)
- Urology (176)